BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1269 related articles for article (PubMed ID: 17177994)

  • 21. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
    Andersson AK; Feldmann M; Brennan FM
    Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
    Leech M; Metz C; Hall P; Hutchinson P; Gianis K; Smith M; Weedon H; Holdsworth SR; Bucala R; Morand EF
    Arthritis Rheum; 1999 Aug; 42(8):1601-8. PubMed ID: 10446857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
    Jain A; Nanchahal J; Troeberg L; Green P; Brennan F
    Arthritis Rheum; 2001 Aug; 44(8):1754-60. PubMed ID: 11508425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M; Parry SL; Brennan FM; Feldmann M
    Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy.
    Andreakos E; Smith C; Kiriakidis S; Monaco C; de Martin R; Brennan FM; Paleolog E; Feldmann M; Foxwell BM
    Arthritis Rheum; 2003 Jul; 48(7):1901-12. PubMed ID: 12847684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages.
    Kim WJ; Kang YJ; Koh EM; Ahn KS; Cha HS; Lee WH
    Immunology; 2005 Feb; 114(2):272-9. PubMed ID: 15667572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
    Castor CW; Smith EM; Bignall MC; Hossler PA
    J Rheumatol; 1997 Nov; 24(11):2080-9. PubMed ID: 9375864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders.
    Wassilew GI; Lehnigk U; Duda GN; Taylor WR; Matziolis G; Dynybil C
    Arthroscopy; 2010 Aug; 26(8):1096-104. PubMed ID: 20678708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes.
    Cha HS; Bae EK; Koh JH; Chai JY; Jeon CH; Ahn KS; Kim J; Koh EM
    J Rheumatol; 2007 Jan; 34(1):16-9. PubMed ID: 17216674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alarmin S100A9 Induces Proinflammatory and Catabolic Effects Predominantly in the M1 Macrophages of Human Osteoarthritic Synovium.
    van den Bosch MH; Blom AB; Schelbergen RF; Koenders MI; van de Loo FA; van den Berg WB; Vogl T; Roth J; van der Kraan PM; van Lent PL
    J Rheumatol; 2016 Oct; 43(10):1874-1884. PubMed ID: 27481901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis.
    Danning CL; Illei GG; Hitchon C; Greer MR; Boumpas DT; McInnes IB
    Arthritis Rheum; 2000 Jun; 43(6):1244-56. PubMed ID: 10857783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.
    Chabaud M; Durand JM; Buchs N; Fossiez F; Page G; Frappart L; Miossec P
    Arthritis Rheum; 1999 May; 42(5):963-70. PubMed ID: 10323452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of intercellular adhesion molecule-1 expression on human synovial fibroblasts by endothelin-1.
    Iwabuchi H; Kasama T; Hanaoka R; Miwa Y; Hatano Y; Kobayashi K; Mori Y; Negishi M; Ide H; Adachi M
    J Rheumatol; 1999 Mar; 26(3):522-31. PubMed ID: 10090156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display.
    Scaife S; Brown R; Kellie S; Filer A; Martin S; Thomas AM; Bradfield PF; Amft N; Salmon M; Buckley CD
    Rheumatology (Oxford); 2004 Nov; 43(11):1346-52. PubMed ID: 15292528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha.
    Redlich K; Kiener HP; Schett G; Tohidast-Akrad M; Selzer E; Radda I; Stummvoll GH; Steiner CW; Gröger M; Bitzan P; Zenz P; Smolen JS; Steiner G
    Arthritis Rheum; 2001 Feb; 44(2):266-74. PubMed ID: 11229456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.